Zhehao Dai

Dr. Zhehao Dai


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Cardiology
Verified
Journal Article
Closed access
ZDZhehao Dai
Zhehao Dai
TATatsuo Aoki
Tatsuo Aoki
YFYoshihiro Fukumoto
Yoshihiro Fukumoto
HSHiroaki Shimokawa
Hiroaki Shimokawa

17 November 2022 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
SYShintaro Yamada
Shintaro Yamada
TKToshiyuki Ko
Toshiyuki Ko
SHSatoshi Hatsuse
Satoshi Hatsuse
Seitaro NomuraSeitaro Nomura
Seitaro Nomura
BZBo Zhang
Bo Zhang
IKIssei Komuro
Issei Komuro
The underlying mechanisms of ventricular remodeling after myocardial infarction (MI) remain largely unknown. In this study, we performed an integrative analysis of spatial transcriptomics and single-nucleus RNA sequencing (snRNA-seq) in a murine MI model and found that mechanical stress-response genes are expressed at the border zone and play a critical role in left ventricular remodeling after MI. An integrative analysis of snRNA-seq and spatial transcriptome of the heart tissue after MI identified the unique cluster that appeared at the border zone in an early stage, highly expressing mechano-sensing genes, such as Csrp3. AAV9-mediated gene silencing and overexpression of Csrp3 demonstrated that upregulation of Csrp3 plays critical roles in preventing cardiac remodeling after MI by regulation of genes associated with mechano-sensing. Overall, our study not only provides an insight into spatiotemporal molecular changes after MI but also highlights that the mechano-sensing genes at the border zone act as adaptive regulators of left ventricular remodeling.

29 October 2024 in International Journal of Medical Informatics
Verified
Journal Article
Open access
MLMingxin Liu
Mingxin Liu
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
ZDZhehao Dai
Zhehao Dai
WHWenbo Huang
Wenbo Huang
LGLin Gu
Lin Gu
TKTakahiro Kiuchi
Takahiro Kiuchi
Study aims and objectives. This study aims to evaluate the accuracy of medical knowledge in the most advanced LLMs (GPT-4o, GPT-4, Gemini 1.5 Pro, and Claude 3 Opus) as of 2024. It is the first to evaluate these LLMs using a non-English medical licensing exam. The insights from this study will guide educators, policymakers, and technical experts in the effective use of AI in medical education and clinical diagnosis. Authors inputted 790 questions from Japanese National Medical Examination into the chat windows of the LLMs to obtain responses. Two authors independently assessed the correctness. Authors analyzed the overall accuracy rates of the LLMs and compared their performance on image and non-image questions, questions of varying difficulty levels, general and clinical questions, and questions from different medical specialties. Additionally, authors examined the correlation between the number of publications and LLMs' performance in different medical specialties. GPT-4o achieved highest accuracy rate of 89.2% and outperformed the other LLMs in overall performance and each specific category. All four LLMs performed better on non-image questions than image questions, with a 10% accuracy gap. They also performed better on easy questions compared to normal and difficult ones. GPT-4o achieved a 95.0% accuracy rate on easy questions, marking it as an effective knowledge source for medical education. Four LLMs performed worst on "Gastroenterology and Hepatology" specialty. There was a positive correlation between the number of publications and LLM performance in different specialties. GPT-4o achieved an overall accuracy rate close to 90%, with 95.0% on easy questions, significantly outperforming the other LLMs. This indicates GPT-4o's potential as a knowledge source for easy questions. Image-based questions and question difficulty significantly impact LLM accuracy. "Gastroenterology and Hepatology" is the specialty with the lowest performance. The LLMs' performance across medical specialties correlates positively with the number of related publications.

30 July 2024 in Circulation
Verified
Journal Article
Closed access
MKManami Katoh
Manami Katoh
Seitaro NomuraSeitaro Nomura
Seitaro Nomura
SYShintaro Yamada
Shintaro Yamada
MIMasamichi Ito
Masamichi Ito
HHHiroki Hayashi
Hiroki Hayashi
IKIssei Komuro
Issei Komuro
BACKGROUND: The heart comprises many types of cells such as cardiomyocytes, endothelial cells (ECs), fibroblasts, smooth muscle cells, pericytes, and blood cells. Every cell type responds to various stressors (eg, hemodynamic overload and ischemia) and changes its properties and interrelationships among cells. To date, heart failure research has focused mainly on cardiomyocytes; however, other types of cells and their cell-to-cell interactions might also be important in the pathogenesis of heart failure. METHODS: Pressure overload was imposed on mice by transverse aortic constriction and the vascular structure of the heart was examined using a tissue transparency technique. Functional and molecular analyses including single-cell RNA sequencing were performed on the hearts of wild-type mice and EC-specific gene knockout mice. Metabolites in heart tissue were measured by capillary electrophoresis-time of flight-mass spectrometry system. The vaccine was prepared by conjugating the synthesized epitope peptides with keyhole limpet hemocyanin and administered to mice with aluminum hydroxide as an adjuvant. Tissue samples from heart failure patients were used for single-nucleus RNA sequencing to examine gene expression in ECs and perform pathway analysis in cardiomyocytes. RESULTS: Pressure overload induced the development of intricately entwined blood vessels in murine hearts, leading to the accumulation of replication stress and DNA damage in cardiac ECs. Inhibition of cell proliferation by a cyclin-dependent kinase inhibitor reduced DNA damage in ECs and ameliorated transverse aortic constriction–induced cardiac dysfunction. Single-cell RNA sequencing analysis revealed upregulation of Igfbp7 (insulin-like growth factor-binding protein 7) expression in the senescent ECs and downregulation of insulin signaling and oxidative phosphorylation in cardiomyocytes of murine and human failing hearts. Overexpression of Igfbp7 in the murine heart using AAV9 (adeno-associated virus serotype 9) exacerbated cardiac dysfunction, while EC-specific deletion of Igfbp7 and the vaccine targeting Igfbp7 ameliorated cardiac dysfunction with increased oxidative phosphorylation in cardiomyocytes under pressure overload. CONCLUSIONS: Igfbp7 produced by senescent ECs causes cardiac dysfunction and vaccine therapy targeting Igfbp7 may be useful to prevent the development of heart failure.

1 August 2014 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
ZDZhehao Dai
Zhehao Dai
YFYoshihiro Fukumoto
Yoshihiro Fukumoto
STShunsuke Tatebe
Shunsuke Tatebe
KSKoichiro Sugimura
Koichiro Sugimura
YMYutaka Miura
Yutaka Miura
HSHiroaki Shimokawa
Hiroaki Shimokawa

6 November 2023 in JACC: Heart Failure
Verified
Journal Article
Open access
ZDZhehao Dai
Zhehao Dai
TKToshiyuki Ko
Toshiyuki Ko
KFKanna Fujita
Kanna Fujita
Seitaro NomuraSeitaro Nomura
Seitaro Nomura
YUYukari Uemura
Yukari Uemura
IKIssei Komuro
Issei Komuro
Reliable predictors of treatment efficacy in heart failure have been long awaited. DNA damage has been implicated as a cause of heart failure. The purpose of this study was to investigate the association of DNA damage in myocardial tissue with treatment response and prognosis of heart failure. The authors performed immunostaining of DNA damage markers poly(ADP-ribose) (PAR) and γ-H2A.X in endomyocardial biopsy specimens from 175 patients with heart failure with reduced ejection fraction (HFrEF) of various underlying etiologies. They calculated the percentage of nuclei positive for each DNA damage marker (%PAR and %γ-H2A.X). The primary outcome was left ventricular reverse remodeling (LVRR) at 1 year, and the secondary outcome was a composite of cardiovascular death, heart transplantation, and ventricular assist device implantation. Patients who did not achieve LVRR after the optimization of medical therapies presented with significantly higher %PAR and %γ-H2A.X. The ROC analysis demonstrated good performance of both %PAR and %γ-H2A.X for predicting LVRR (AUCs: 0.867 and 0.855, respectively). There was a negative correlation between the mean proportion of DNA damage marker-positive nuclei and the probability of LVRR across different underlying diseases. In addition, patients with higher %PAR or %γ-H2A.X had more long-term clinical events (PAR HR: 1.63 [95% CI: 1.31-2.01; P < 0.001]; γ-H2A.X HR: 1.48 [95% CI: 1.27-1.72; P < 0.001]). DNA damage determines the consequences of human heart failure. Assessment of DNA damage is useful to predict treatment efficacy and prognosis of heart failure patients with various underlying etiologies.